Essex Bio-Technology Limited
Essex Bio-Technology Limited (1061.HK) Stock Overview
Explore Essex Bio-Technology Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.9B
P/E Ratio
9.61
EPS (TTM)
$0.53
ROE
0.15%
1061.HK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Essex Bio-Technology Limited (1061.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.73.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.61 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.